H. Cao
8 Papers
H. Cao is an academic researcher. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
H. Cao,Tian Huang,Mingrui Dai,Xiangyi Kong,Hanyuan Liu,Zhiying Zheng,Guoqiang Sun,Guangshun Sun,Dawei Rong,Zehua Jin,Weiwei Tang,Yongxiang Xia +11 more
TL;DR: This review will discuss the interactions between immune cells and stromal cells (including cancer-associated fibroblasts, endothelial cells) in the TME of CCA and current research results on TME and recent advances in immunotherapy.
CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening
Guangshun Sun,Siqi Zhao,Zhongguo Fan,Yuliang Wang,Hanyuan Liu,H. Cao,Guoqiang Sun,Tian Huang,Hongzhou Cai,Hong Pan,Dawei Rong,Yun Gao,Weiwei Tang +12 more
TL;DR: Chondroitin sulfate synthase 1 (CHSY1) may be involved in CRC metastasis and Artemisinin significantly inhibits CHSY1 activity and in combination with anti-PD1 could synergistically treat CRC liver metastases.
22
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao,Zhiqiang Chen,H. Cao,Wenhao Wu,Xinglin Chu,Hanyuan Liu,Leyao Zhang,Hongfei Zhu,Hongzhou Cai,Xiaolan Lu,Junfeng Shi,Yuan Liu,Tingting Feng +12 more
TL;DR: A review about the development, challenges and prospects of COVID-19 vaccines can be found in this article , which can provide more insights into all aspects of the vaccines, and it can be used to provide a more accurate analysis of the vaccine use in globe.
18
GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
Dawei Rong,Yuliang Wang,Lei Liu,H. Cao,Tian Huang,Hanyuan Liu,Xi-shang Hao,Guangshun Sun,Guoqiang Sun,Zhiying Zheng,Junwei Kang,Yongxiang Xia,Ziyi Chen,Weiwei Tang,Xuehao Wang +14 more
TL;DR: In this paper , the effects of GLI-similar 1 (GLIS1) on modulating the anticancer potency of CD8+ T cells in hepatocellular carcinoma (HCC) were explored.
CHSY1 Promotes CD8 T Cell Exhaustion Through Activation of Succinate Metabolism Pathway Leading to Colorectal Cancer Liver Metastasis Based on CRISPR/Cas9 Screening
Guangshun Sun,Siqi Zhao,Hanyu Liu,Yuliang Wang,Li Liu,H. Cao,Xiao Li,Guoqiang Sun,Tian Huang,Dawei Rong,Yun Gao,Xue-Hao Wang,Weiwei Tang +12 more
6